Literature DB >> 12783163

The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes.

D Devendra1, T S Galloway, S J Horton, A Evenden, U Keller, T J Wilkin.   

Abstract

AIM/HYPOTHESIS: Radiobinding assays (RBA) are unable to differentiate insulin autoantibodies (IAA) from insulin antibodies (IA). We sought to establish whether random peptide phage display might generate reagents with which to distinguish IAA idiotopes from IA idiotopes.
METHODS: Two insulin-binding sera were used to select phagotopes from a phage library. The first, designated IAS, came from an insulin-treated patient with the insulin autoimmune syndrome, and was known to contain both IA and a high titre of human insulin specific (B30 threonine dependent) IAA. The second, designated IDD, was taken from a newly-diagnosed IAA(+) Type 1 diabetic patient. Phage colonies selected by insulin-purified IgG extracts of IAS and IDD were selected at random for DNA sequencing, and tested for their reactivity with insulin antibodies and ability to distinguish disease-associated idiotopes.
RESULTS: Seven phagotopes bound IAS and the phagotope designated IAS-9, corresponding to sequence KRSRLDV, gave the highest binding standard deviation (SD) score. Seven phagotopes bound IDD and the phagotope designated IDD-10, corresponding to sequence LGRGGSK, bound most strongly. IAS-9 was able to displace insulin binding in IAS and all of ten insulin-treated Type 2 diabetic patients, but not the IAA present in any of the eight patients with newly-diagnosed Type 1 diabetes. IDD-10, on the other hand, could displace insulin binding detected in the sera of eight patients with untreated Type 1 diabetes (IAA), but not in IAS or sera of the insulin-treated Type 2 diabetics.
CONCLUSION: Phagotopes provide reagents which between them can distinguish positively as well as negatively diabetes-associated IAA from non-diabetes associated IAA and from IA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783163     DOI: 10.1007/s00125-003-1107-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display.

Authors:  M J Rowley; M Scealy; J C Whisstock; J A Jois; L C Wijeyewickrema; I R Mackay
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

2.  [Spontaneous hypoglycemia with insulin-autoimmunity].

Authors:  Y Hirata; H Nishimura; M Tominaga; H Ishizu; M Arimichi
Journal:  Nihon Naika Gakkai Zasshi       Date:  1972-10

3.  The structure of 2Zn pig insulin crystals at 1.5 A resolution.

Authors:  E N Baker; T L Blundell; J F Cutfield; S M Cutfield; E J Dodson; G G Dodson; D M Hodgkin; R E Hubbard; N W Isaacs; C D Reynolds
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1988-07-06       Impact factor: 6.237

4.  A novel micro-assay for insulin autoantibodies.

Authors:  A J Williams; P J Bingley; E Bonifacio; J P Palmer; E A Gale
Journal:  J Autoimmun       Date:  1997-10       Impact factor: 7.094

5.  Use of the phage display technique for detection of epitopes recognized by polyclonal rabbit gliadin antibodies.

Authors:  A A Osman; H Uhlig; B Thamm; J Schneider-Mergener; T Mothes
Journal:  FEBS Lett       Date:  1998-08-14       Impact factor: 4.124

Review 6.  Islet cell antigens in the prediction and prevention of insulin-dependent diabetes mellitus.

Authors:  E Bonifacio; M R Christie
Journal:  Ann Med       Date:  1997-10       Impact factor: 4.709

7.  ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.

Authors:  Dongmei Miao; Liping Yu; Claudio Tiberti; David D Cuthbertson; Marian Rewers; Umberto di Mario; George S Eisenbarth; Francesco Dotta
Journal:  J Autoimmun       Date:  2002-03       Impact factor: 7.094

8.  Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.

Authors:  A G Ziegler; M Hummel; M Schenker; E Bonifacio
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

9.  Characterization of insulin autoantibodies in relatives of patients with type I diabetes.

Authors:  L Castaño; A G Ziegler; R Ziegler; S Shoelson; G S Eisenbarth
Journal:  Diabetes       Date:  1993-08       Impact factor: 9.461

10.  Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition.

Authors:  Q X Hua; S E Shoelson; M A Weiss
Journal:  Biochemistry       Date:  1992-12-01       Impact factor: 3.162

View more
  6 in total

1.  Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes.

Authors:  T R Hall; J W Thomas; C J Padoa; C Torn; M Landin-Olsson; E Ortqvist; C S Hampe
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 2.  Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.

Authors:  Elena Pipi; Marietta Marketou; Alexandra Tsirogianni
Journal:  World J Diabetes       Date:  2014-08-15

3.  Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.

Authors:  Rachel H Bonami; James W Thomas
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

4.  Epitope analysis of insulin autoantibodies using recombinant Fab.

Authors:  C J Padoa; N J Crowther; J W Thomas; T R Hall; L M Bekris; C Torn; M Landin-Olsson; E Ortqvist; J P Palmer; A Lernmark; C S Hampe
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

5.  A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes.

Authors:  Khyati Girdhar; Qian Huang; I-Ting Chow; Tommi Vatanen; Claudia Brady; Amol Raisingani; Patrick Autissier; Mark A Atkinson; William W Kwok; C Ronald Kahn; Emrah Altindis
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-25       Impact factor: 12.779

6.  The effects of anti-insulin antibodies and cross-reactivity with human recombinant insulin analogues in the E170 insulin immunometric assay.

Authors:  Serim Kim; Yeo Min Yun; Mina Hur; Hee Won Moon; Jin Q Kim
Journal:  Korean J Lab Med       Date:  2011-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.